Where chronic low back pain treatment is heading
Chronic low back pain · Updated Nov 12, 2026
Staying active, exercise and learning to manage pain work better than most pills, injections or operations. No new drug has succeeded in years. Research now is on treating the disc itself, on weight-loss drugs, and on matching people to the right approach.
- 380studies open or running
- 9phase 3 trials
- 963papers published this year
- 92NIH-funded projects
-
Now
Nov 2026
Coached self-management beat medical careHappened 64% vs 55% cut pain impact by half
A large trial found a personalized self-management program worked better than standard medical care or spinal manipulation.
64% vs 55%: had their pain impact cut by half or more, self-management vs medical care.
New painkiller no better than placeboHappened 2.02 vs 1.98 points, no better than placebo
Suzetrigine, the first new type of painkiller in decades, did not beat placebo for sciatica.
2.02 vs 1.98: points of pain relief on a 0 to 10 scale, suzetrigine vs placebo.
Online mindfulness: a small benefitHappened
Group video sessions improved pain, by less than the amount set as meaningful.
-
6 months
by May 2027
Phone coaching in community clinicsPossible
A 500-person NIH-funded trial of pain coaching by phone in clinics serving low-income patients is fully enrolled and past its completion date.
Melatonin trial finishesPossible
222 people given melatonin or placebo in the Netherlands.
-
12 months
by Nov 2027
Stem cell disc injection resultPossible
A 300-person phase 3 trial of donor stem cells injected into a worn disc finishes in July 2027.
Antibiotics for back pain, retestedPossible
A placebo-controlled trial of amoxicillin for a subgroup with specific MRI changes finishes in August 2027.
A weight-loss drug in back painPossible
Retatrutide in 586 people with obesity and back pain finishes in September 2027.
-
3 years
by late 2029
New painkillers from a large testing programLong shot 2.02 vs 1.98 points, no better than placebo
Lilly is testing several experimental pain drugs side by side in one program.
2.02 vs 1.98: points of pain relief on a 0 to 10 scale, suzetrigine vs placebo.
Treating sleep to treat painPossible
A 300-person trial of insomnia therapy in people with back pain finishes in 2029.
-
5 years
by late 2031
Semaglutide tested directly for back painLong shot
A 250-person trial is planned to finish in 2031. It had not opened when last updated.
Matching people to the right treatmentLong shot
NIH-funded studies are testing which combination of treatments works for which person.
The research paths
Self-management and mind-body care
64% vs 55% cut pain impact by halfDetails and 2 trialsHide
The best-supported approach, with new trials on how to deliver it by phone and video.
WatchWhether results hold in clinics with few resources.
Treating the disc
Details and 2 trialsHide
Injecting stem cells into a worn disc, or giving antibiotics to people whose MRI suggests low-grade infection.
WatchThe stem cell phase 3 result in 2027.
New painkillers
2.02 vs 1.98 points, no better than placeboDetails and 2 trialsHide
Drug after drug has failed for long-term back pain. The newest class did not beat placebo for sciatica.
WatchLilly's program testing several drugs at once.
Weight-loss drugs
Details and 2 trialsHide
Testing whether losing weight with the new injections reduces back pain.
WatchRetatrutide, the first to report.
Borrowed from other conditions
From Obesity treatment
Retatrutide and semaglutide
Phase 3
Weight-loss injections, tested for whether less weight means less back pain.
From Pain after surgery
Suzetrigine
2.02 vs 1.98 points, no better than placebo
Phase 2 missed
Approved for short-term pain. Did not beat placebo for sciatica.
From Infection treatment
Amoxicillin
Phase 3
A common antibiotic, on the theory that some disc pain involves low-grade infection.
From Regenerative medicine
Stem cells
Phase 3
Donor stem cells injected into the disc to calm inflammation.
From Sleep medicine
Insomnia therapy
Phase 2
Cognitive behavioral therapy for insomnia, since poor sleep worsens pain.
Open to join now
-
Chronic pain including back pain
Lilly program testing several pain drugs
Locations and eligibility → -
Chronic pain
LY4065967 pain drug
Locations and eligibility → -
Back pain with poor sleep, Virginia
Insomnia therapy for back pain
Locations and eligibility → -
Chronic low back pain, Boston
Mild electrical brain stimulation
Locations and eligibility →
See every recruiting back pain trial →
When the trials finish
Completion dates the trials registered. Results usually follow 3 to 12 months later.
- Heating up
- Maturing
- Early
- Cooling
- Fully enrolled, waiting on results
- Still enrolling
Knowledge on the way
Not treatments yet: detection, causes and how care is delivered. Mostly NIH-funded.
- AreaQuestionFunded throughNews likely
- Care Predicting who will benefit from mindfulness for back painWorcester Polytechnic Institute · NIH Funded through Aug 2028 News likely 2027–2028
- Care Which combination of treatments works for which personUniversity of Michigan · NIH Funded through Jul 2030 News likely 2028–2030
- Causes The whole-person experience of back painUniversity of Pittsburgh · NIH Funded through Jul 2030 News likely 2028–2030
- Causes Back pain in older adults and the role of hip problemsUniversity of Delaware · NIH Funded through Aug 2031 News likely 2029–2031
- Detection An ultrasound-based marker for muscle-related back painUniversity of Pittsburgh · NIH Funded through Aug 2027 News likely 2027–2028
What just happened
Coached self-management beats medical care
64% vs 55% had pain impact cut by half or more.
Online mindfulness: small benefit
451 people; improvement below the meaningful threshold.
Suzetrigine no better than placebo in sciatica
2.02 vs 1.98 points of pain relief.
Standard treatment today
- First stepsStay active, exercise therapy, and education about pain. Imaging is usually not needed.
- Added supportCognitive behavioral therapy, mindfulness, yoga, or supervised rehabilitation.
- MedicinesAnti-inflammatory painkillers for short periods; duloxetine for some. Opioids are discouraged.
- ProceduresInjections and surgery help selected people with specific causes, not back pain in general.
How to read this page, and sourcesHow to read this page, and sources
- Back pain has many causes. A treatment that helps one group often fails when tested in everyone.
- The self-management trial was in people at risk of long-term pain, not only those who already had it for years.
- Completion dates are what each trial registered. Results usually follow 3 to 12 months later.
- Forecasts are editorial judgments by Find a Trial, not predictions from sponsors or regulators.
See back pain trials recruiting now →